Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 179Urinary Bladder Neoplasms 31Carcinoma, Renal Cell 19Kidney Neoplasms 18Breast Neoplasms 13Wilms Tumor 11Neoplasms 10Neoplasm Metastasis 10Lung Neoplasms 9Testicular Neoplasms 8Testicular Germ Cell Tumor 6Melanoma 6Carcinoma, Non-Small-Cell Lung 6Non-Muscle Invasive Bladder Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Endometrial Neoplasms 5Dendritic Cell Sarcoma, Interdigitating 5Burkitt Lymphoma 5Vaginal Neoplasms 4Uterine Cervical Neoplasms 4Urethral Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Seminoma 4Sarcoma 4Recurrence 4Rectal Neoplasms 4Radiation Injuries 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4

Interventions

enzalutamide 2sipuleucel-T 1pazopanib 1capivasertib 1Watchful Waiting 1STA 9090 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiosurgery 1Dutasteride 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of the Prostate × Radiotherapy × Genitourinary × Clear all
NCT01517451 2026-02-11

Radiation and Androgen Ablation for Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
45 enrolled 11 charts
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡